Advertisement
Advertisement
CODX
Co-Diagnostics, Inc. Common Stock
2.36
USDSponsored
-0.08
-3.28%
Jul 21, 15:59 UTC -4
Closed
After-Market
2.35
-0.01
-0.47%
CODX Earnings Reports
Positive Surprise Ratio
CODX beat 16 of 30 last estimates.
53%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$169.83K
/-$3.06
Implied change from Q1 26 (Revenue/ EPS)
+16.36%
/-24.44%
Implied change from Q2 25 (Revenue/ EPS)
+4.19%
/-55.65%
Co-Diagnostics, Inc. Common Stock earnings per share and revenue
On May 14, 2026, CODX reported earnings of -4.05 USD per share (EPS) for Q1 26, missing the estimate of -3.82 USD, resulting in a -6.14% surprise. Revenue reached 145.95 thousand, compared to an expected 166.77 thousand, with a -12.48% difference. The market reacted with a -21.17% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -3.06 USD, with revenue projected to reach 169.83 thousand USD, implying an decrease of -24.44% EPS, and increase of 16.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Cryo-Cell International Inc.
Report Date
Jul 15, 2026 For Q2 26
Estimate
$0.00
Actual
$0.07
Surprise
0.00%
Danaher Corporation
Report Date
Jul 21, 2026 For Q2 26
Estimate
$1.85
Actual
$1.94
Surprise
+4.68%
HCA Healthcare, Inc.
Report Date
Jul 14, 2026 For Q2 26
Estimate
$7.54
Actual
$7.62
Surprise
+1.03%
Elevance Health, Inc.
Report Date
Jul 15, 2026 For Q2 26
Estimate
$6.26
Actual
$7.45
Surprise
+18.85%
FAQ
What were Co-Diagnostics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Co-Diagnostics, Inc. Common Stock reported EPS of -$4.05, missing estimates by -6.14%, and revenue of $145.95K, -12.48% below expectations.
How did the market react to Co-Diagnostics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -21.17%, changed from $1.63 before the earnings release to $1.28 the day after.
When is Co-Diagnostics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Co-Diagnostics, Inc. Common Stock's next earnings report?
Based on 4
analysts, Co-Diagnostics, Inc. Common Stock is expected to report EPS of -$3.06 and revenue of $169.83K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement